ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,005.20
      -0.91%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      81.875
      0.00%
      Bitcoin
      66,685.33
      -0.05%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Zymeworks Inc (ZYME) Quote

      Zymeworks Inc

      Zymeworks Inc (ZYME)

      NASDAQ
      9.78
      -0.03
      (-0.31%)
      Closed July 19 4:00PM
      Delayed by 15 minutes
      9.78
      0.02
      (0.20%)
      After Hours: 4:11PM
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      9.78
      Bid
      9.27
      Ask
      10.41
      Volume
      597,545
      9.65 Day's Range 9.95
      6.015 52 Week Range 13.14
      Market Cap
      693.615M
      Previous Close
      9.81
      Open
      9.87
      Last Trade
      2
      @
      9.68
      Last Trade Time
      Financial Volume
      $ 5,855,160
      VWAP
      9.7987
      Average Volume (3m)
      637,900
      Shares Outstanding
      70,704,890
      Dividend Yield
      -
      PE Ratio
      -3.83
      Earnings Per Share (EPS)
      -1.68
      Revenue
      76.3M
      Net Profit
      -118.67M

      About Zymeworks Inc

      Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiat... Zymeworks Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development and commercialization of next-generation multifunctional biotherapeutics. Its suite of therapeutic platforms and its fully integrated drug development engine enable precise engineering of differentiated product candidates. Its lead clinical candidate, zanidatamab, is a novel Azymetric HER2-targeted bispecific antibody currently being evaluated in multiple Phase 1, Phase 2, and pivotal clinical trials globally as a targeted treatment option for patients with solid tumors that express HER2. The company is also advancing a deep preclinical pipeline in oncology and other therapeutic areas. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.zymeworks.com
      Headquarters
      North Vancouver, British Columbia, Can
      Founded
      1970
      Zymeworks Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ZYME. The last closing price for Zymeworks was $9.81. Over the last year, Zymeworks shares have traded in a share price range of $ 6.015 to $ 13.14.

      Zymeworks currently has 70,704,890 shares outstanding. The market capitalization of Zymeworks is $693.61 million. Zymeworks has a price to earnings ratio (PE ratio) of -3.83.

      ZYME Latest News

      More News

      Zymeworks To Report Second Quarter 2024 Financial Results and Host Conference Call on August 1, 2024

      VANCOUVER, British Columbia, July 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

      July 11 2024
      GlobeNewswire Inc.

      Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers

      VANCOUVER, British Columbia, June 17, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

      June 17 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      June 10 2024
      Edgar (US Regulatory)

      Zymeworks Announces China NMPA Acceptance of Biologics License Application for Zanidatamab for Second-Line Treatment of Biliary Tract Cancer

      Pursuant to the terms of the licensing agreement between Zymeworks and BeiGene, Zymeworks is entitled to receive an $8 million milestone payment from BeiGene and remains eligible to receive up to...

      June 10 2024
      GlobeNewswire Inc.

      Zymeworks Announces Participation in Upcoming Investor Conferences

      VANCOUVER, British Columbia, May 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

      May 28 2024
      GlobeNewswire Inc.

      Zymeworks Provides Corporate Update and Reports First Quarter 2024 Financial Results

      Reported $420.5 million in cash resources as of March 31, 2024, which when combined with certain anticipated regulatory milestone payments provides projected cash runway into 2H 2027Completion of...

      May 02 2024
      GlobeNewswire Inc.

      Zymeworks Announces Participation in Upcoming Investor Conferences

      VANCOUVER, British Columbia, April 30, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

      April 30 2024
      GlobeNewswire Inc.

      Zymeworks To Report First Quarter 2024 Financial Results and Host Conference Call on May 2, 2024

      VANCOUVER, British Columbia, April 11, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

      April 11 2024
      GlobeNewswire Inc.

      Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

      VANCOUVER, British Columbia, April 08, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

      April 08 2024
      GlobeNewswire Inc.

      Zymeworks Announces Appointment of Dr. Neil Gallagher to its Board of Directors

      VANCOUVER, British Columbia, March 28, 2024 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional...

      March 28 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.15-1.510574018139.9310.629.6568058410.16276484CS
      41.2815.05882352948.510.628.215790669.23146213CS
      121.6620.44334975378.1210.627.976379008.98815358CS
      26-0.13-1.311806256319.9113.147.976080119.80680643CS
      521.8923.95437262367.8913.146.0155254589.05962686CS
      1563.453.29153605026.3813.146.0156223328.80746945CS
      2603.453.29153605026.3813.146.0156223328.80746945CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		262.73M
      AUGXAugmedix Inc
      $ 2.27
      (147.71%)
      		21.87M
      XCURExicure Inc
      $ 0.5351
      (76.02%)
      		14.02M
      PSNLPersonalis Inc
      $ 3.83
      (56.33%)
      		22.76M
      MDBHMDB Capital Holdings LLC
      $ 10.675
      (37.21%)
      		126.13k
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		124.61M
      HYZNHyzon Motors Inc
      $ 0.149
      (-47.54%)
      		23.63M
      MEDSTRxADE Health Inc
      $ 14.92
      (-33.45%)
      		223.27k
      SILOSilo Pharma Inc
      $ 2.50
      (-27.95%)
      		11.93M
      KITTNauticus Robotics Inc
      $ 0.0935
      (-27.46%)
      		28.36M
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		262.73M
      NVDANVIDIA Corporation
      $ 117.93
      (-2.61%)
      		206.41M
      SXTP60 Degrees Pharmaceuticals Inc
      $ 0.2602
      (5.77%)
      		202.14M
      SQQQProShares UltraPro Short QQQ
      $ 8.46
      (2.79%)
      		184.21M
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		119.98M

      Discussion

      View Full Feed
      fuagf fuagf 57 seconds ago
      LOLOL I read her Goodman's Pisces page, she kept saying "That's me .. that's me." She was Sagittarius.

      The kinda mean trick i played once on my ex-wife.
      just Scottie just Scottie 1 minute ago
      Did u get an email to vote for the split?
      ALLR
      BDEZ BDEZ 2 minutes ago
      Sue and bankrupt her. It’s what they did to Alex Jones

      https://x.com/hodgetwins/status/1813905871954448640
      axelvento axelvento 3 minutes ago
      Moderna to Report Second Quarter 2024 Financial Results on Thursday, August 1, 2024
      MRNA
      OMOLIVES OMOLIVES 4 minutes ago
      Current real share price @ 0.0000625 per share. Reality.
      HMBL
      kund kund 5 minutes ago
      Hope DOJ and SEC sue Misleading for his false statements and promises over the last 10 years. The guy deserves orange suits. In fact, he deserves jail time more than SAVA executives. MF said mid-2024 AD RNA data and Rett trial design would be PR'd, and we already crossed the midpoint but still have
      AVXL
      BDEZ BDEZ 6 minutes ago
      Wall Street Journal U.S. reporter is sentenced to 16 years in prison by a Russian court on 'espionage' charges

      https://x.com/unlimited_ls/status/1814280336110735795
      SSKILLZ1 SSKILLZ1 6 minutes ago
      Pick 4 Contest #20 Results In (Week 9)

      Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

      https://investorshub.advfn.com/Pick-4-Contest-No-20-42933
      SSKILLZ1 SSKILLZ1 6 minutes ago
      Pick 4 Contest #20 Results In (Week 9)

      Hope everyone enjoys the stats. Below is the link to the board. Have a great weekend everyone.

      https://investorshub.advfn.com/Pick-4-Contest-No-20-42933
      Milesblue42 Milesblue42 7 minutes ago
      QuickCash4Me, psst SteveReinharz Diluted again. Now 11,303,537,143

      Post proof or move on. You have hundreds of posts with the same claims. We hear you. You don’t need to post the same info each and every day. If you have proof, report it to the SEC and move on. If you don’t report it,
      AITX
      fuagf fuagf 8 minutes ago
      LOLs nothing like a good source of fiber

      https://www.eatingwell.com/thmb/u1uyhj6raQnEl-u6ylIeZREGvCE=/750x0/filters:no_upscale():max_bytes(150000):strip_icc():format(webp)/guiness-is-good-for-you-ad-2ecd42c373484e97b9ccd9cff7b6f599.jpg

      Bamforth says there are plenty of
      skitahoe skitahoe 8 minutes ago
      The EV market will do far better under a Democrat, and so will the car makers by making cars that aren't adding to climate change. As for CRTG, if it's technology becomes a key to electric cars that have ranges in the 500 mile or greater and that recharge in 30 minutes of less, no one will prefer g
      CRTG
      Not likely Not likely 9 minutes ago
      Your whole post calls out the unbelievable and sketchy...

      That's what you get with scams and the aliases pumping them.

      This is not a new tandem by any means.


      Well done.
      SPZI
      INEEDMONEY INEEDMONEY 9 minutes ago
      My point exactly !! I missed of of those ! But making the same mistake !
      HIRU
      SSKILLZ1 SSKILLZ1 9 minutes ago
      Pick 4 Contest #20 Standings (Week 9)

      Congrats to our current leader KNOWLEDGEISKING up 54.50% so far in the contest. There are 15/34 portfolio up in the contest or 44.12%. So without any further ado the info. is below.
      [pre]
      Alias % Gain/Loss
      tdbowieknife tdbowieknife 10 minutes ago
      What settlement?

      Anything Klug manages to collect, and I doubt he ever collects anything, he's keeping it for himself. Why would he share it with a bunch of dummies he lied to and scammed??




      ..


      .
      mypenneys mypenneys 11 minutes ago
      boarddork we have been on this board for many years together and at the Bank America Shareholders once a year meetings.And Lodas appeared on this board many years later. I never understood why. He claimed to have around 150,000 shares and it sounded like he claimed he had escrow shares. And I cou
      COOP
      BDEZ BDEZ 11 minutes ago
      Sheila Jackson Lee dead at 74

      https://x.com/stillgray/status/1814500006960759020
      SSKILLZ1 SSKILLZ1 12 minutes ago
      The Picks For Pick 4 Contest #20 (Revised)

      Commentary: This basically shows what everyone has now in the contest. The bolded Picks are things that were changed since the start of the contest.
      [pre]
      Alias SP #1 SP #2 SP &#x
      ABAT ACHR AEMD
      gorbec1 gorbec1 13 minutes ago
      What’s funny is reading your post but having know idea what his name is saying cause I don’t read it lol
      MCIC
      SSKILLZ1 SSKILLZ1 13 minutes ago
      Trades Available For July

      Commentary: we had 3/32 People makes trades this month so far. Remember freezes/sells with no buys aren't considered trades. Hope this helps.
      [pre]
      Alias JUL
      1 2MORROWSGAINS 1
      2 BLACKCAT 1
      3 BOBWINS
      Gary 608 Gary 608 13 minutes ago
      Like I said before, it's a shame the stock market ended up this way with greedy low lifes dumping into the bid to make their daily earnings..It ruins it for the honest investor who wants to build this up in their savings portfolios. I still have a hunch that this stock is the one that is being abuse
      GMGI
      blackhawks blackhawks 14 minutes ago
      It 'decreases transit time'. Like a cop in your intestines; move along there, 💩.
      SSKILLZ1 SSKILLZ1 14 minutes ago
      Individual Stock Returns

      Please note this only is a list of the original stocks picked in the contest, it doesn't include any stock traded into during the contest. Hope this helps.
      [pre]
      Symbol % Move
      1 PSIX 130.00%
      2 CRDO 56.17%
      3 TNZ.TO 51.63%
      ABAT ACHR AEMD

      Your Recent History

      NASDAQ
      ZYME
      Zymeworks
      NASDAQ
      GMTC
      Delayed Upgrade Clock